DK1047446T3 - Vaccinesammensætning til Herpes Simplex virus og fremgangsmåder til anvendelser deraf - Google Patents

Vaccinesammensætning til Herpes Simplex virus og fremgangsmåder til anvendelser deraf

Info

Publication number
DK1047446T3
DK1047446T3 DK99902294T DK99902294T DK1047446T3 DK 1047446 T3 DK1047446 T3 DK 1047446T3 DK 99902294 T DK99902294 T DK 99902294T DK 99902294 T DK99902294 T DK 99902294T DK 1047446 T3 DK1047446 T3 DK 1047446T3
Authority
DK
Denmark
Prior art keywords
methods
herpes simplex
vaccine composition
simplex virus
virus
Prior art date
Application number
DK99902294T
Other languages
English (en)
Inventor
Laure Aurelian
Original Assignee
Univ Maryland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland filed Critical Univ Maryland
Application granted granted Critical
Publication of DK1047446T3 publication Critical patent/DK1047446T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK99902294T 1998-01-16 1999-01-15 Vaccinesammensætning til Herpes Simplex virus og fremgangsmåder til anvendelser deraf DK1047446T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/008,388 US6054131A (en) 1998-01-16 1998-01-16 Vaccine composition for herpes simplex virus and method of using
PCT/US1999/000920 WO1999036084A1 (en) 1998-01-16 1999-01-15 Vaccine composition for herpes simplex virus and methods of using

Publications (1)

Publication Number Publication Date
DK1047446T3 true DK1047446T3 (da) 2004-03-29

Family

ID=21731361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99902294T DK1047446T3 (da) 1998-01-16 1999-01-15 Vaccinesammensætning til Herpes Simplex virus og fremgangsmåder til anvendelser deraf

Country Status (11)

Country Link
US (2) US6054131A (da)
EP (1) EP1047446B1 (da)
JP (1) JP2002509113A (da)
AT (1) ATE254474T1 (da)
AU (1) AU742281B2 (da)
CA (1) CA2318439A1 (da)
DE (1) DE69912925T2 (da)
DK (1) DK1047446T3 (da)
ES (1) ES2212521T3 (da)
PT (1) PT1047446E (da)
WO (1) WO1999036084A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060141483A1 (en) * 2004-12-23 2006-06-29 Calton Gary J Stabilization of viral compositions
US7344839B2 (en) * 2004-12-23 2008-03-18 Aurx, Inc. Virus preparations and methods
AU2006258655A1 (en) * 2005-06-14 2006-12-21 Dnavec Corporation Method for production of antibody
JP5284780B2 (ja) * 2005-06-23 2013-09-11 ザ ユニバーシティ オブ ヒューストン 癌の治療のための単純ヘルペスウイルス２型変異体の使用
US20070122344A1 (en) 2005-09-02 2007-05-31 University Of Rochester Medical Center Office Of Technology Transfer Intraoperative determination of nerve location
EP1948232A4 (en) * 2005-11-18 2010-09-22 Univ Ohio State Res Found VIRAL GENE PRODUCTS AND VACCINATION METHODS FOR PREVENTING ASSOCIATED VIRAL DISEASES
US7790203B2 (en) * 2005-12-13 2010-09-07 Lowder Tom R Composition and regimen for the treatment of herpes simplex virus, herpes zoster, and herpes genitalia epidermal herpetic lesions
EP2054036B1 (en) * 2006-07-24 2019-12-18 Singh-Broemer and Company, Inc. Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
US20080161744A1 (en) 2006-09-07 2008-07-03 University Of Rochester Medical Center Pre-And Intra-Operative Localization of Penile Sentinel Nodes
US8406860B2 (en) 2008-01-25 2013-03-26 Novadaq Technologies Inc. Method for evaluating blush in myocardial tissue
US10219742B2 (en) 2008-04-14 2019-03-05 Novadaq Technologies ULC Locating and analyzing perforator flaps for plastic and reconstructive surgery
WO2009135178A2 (en) 2008-05-02 2009-11-05 Flower Robert W Methods for production and use of substance-loaded erythrocytes (s-les) for observation and treatment of microvascular hemodynamics
EP2285417B1 (en) 2008-05-14 2016-08-10 Novadaq Technologies Inc. Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging
US10492671B2 (en) 2009-05-08 2019-12-03 Novadaq Technologies ULC Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest
AU2010249330B2 (en) * 2009-05-22 2015-11-05 Genocea Biosciences Inc. Vaccines against Herpes Simplex Virus type 2: compositions and methods for eliciting an immune response
CA2856697A1 (en) 2010-11-24 2012-06-07 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
US9624273B2 (en) 2011-11-23 2017-04-18 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
CA2914778A1 (en) 2012-06-21 2013-12-27 Novadaq Technologies Inc. Quantification and analysis of angiography and perfusion
JP6549705B2 (ja) 2014-09-29 2019-07-24 ノバダック テクノロジーズ ユーエルシー 自己蛍光の存在下での、生物的物質内のターゲット蛍光体のイメージング
CN107427247B (zh) 2014-10-09 2021-06-04 史赛克欧洲运营有限公司 使用荧光介导的光电容积描记法的组织中的绝对血液流动的定量
US10350288B2 (en) 2016-09-28 2019-07-16 Genocea Biosciences, Inc. Methods and compositions for treating herpes
CA3049922A1 (en) 2017-02-10 2018-08-16 Novadaq Technologies ULC Open-field handheld fluorescence imaging systems and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4347127A (en) * 1981-01-29 1982-08-31 Gulf & Western Manufacturing Company Apparatus and method for froth flotation separation of the components of a slurry
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
US5219567A (en) * 1982-03-24 1993-06-15 The University Of Birmingham Vaccine against herpes viruses
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine

Also Published As

Publication number Publication date
AU2231299A (en) 1999-08-02
WO1999036084A1 (en) 1999-07-22
PT1047446E (pt) 2004-04-30
US6054131A (en) 2000-04-25
DE69912925D1 (de) 2003-12-24
EP1047446A4 (en) 2001-12-19
US6207168B1 (en) 2001-03-27
JP2002509113A (ja) 2002-03-26
DE69912925T2 (de) 2004-09-02
ATE254474T1 (de) 2003-12-15
EP1047446B1 (en) 2003-11-19
AU742281B2 (en) 2001-12-20
CA2318439A1 (en) 1999-07-22
EP1047446A1 (en) 2000-11-02
ES2212521T3 (es) 2004-07-16

Similar Documents

Publication Publication Date Title
DK1047446T3 (da) Vaccinesammensætning til Herpes Simplex virus og fremgangsmåder til anvendelser deraf
DK1021547T3 (da) Vaccineformuleringer indeholdende papillomviruskapsomer og fremgangsmåder til anvendelse heraf
DK1584685T3 (da) Tumorassocieret antigenderivater fra Mage-familien, anvendt til fremstilling af fusionsproteiner med T-hjælper epitoper og sammensætninger til vaccination
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
ATE287728T1 (de) Adjuvierte rekombinante lebendimpfstoffe gegen influenza- oder herpesviren
ATE264863T1 (de) 28-epirapaloge
HUP0101047A1 (hu) Kombinált vakcinakészítmények
GB9711964D0 (en) Live attenuated vaccines
ID17860A (id) Komposisi vaksin
NO910728D0 (no) Fremgangsmaate for aa sementere olje- og gass-broenner.
NO20002504L (no) Adenovirusvektorer og fremgangsmÕte for Õ redusere homologe rekombinasjonsfenomener
ATE377428T1 (de) Rotavirus-impfstoff
AU1508699A (en) Live attenuated influenza vaccine
DK1053017T3 (da) Vacciner omfattende interleukin-12 og herpes simplex virusantigen
DE69738512D1 (de) Epstein-barr virus type b ctl epitopen
DK0538341T3 (da) EHV-4-gycoproteinvaccine.
ATE341339T1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
DK1131414T3 (da) Stabile, svækkede rabiesvirusmutanter og levende vacciner deraf
ATE295182T1 (de) Zusammensetzungen zur immunverstärkung von impfstoffen
BG101145A (en) USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPETIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA
NO991227D0 (no) PTX-sensitive G-proteiner, deres fremstilling og bruk
AU3487799A (en) Improved live attenuated viruses for use as vectors or vaccines
AU2231499A (en) Novel vaccine compositions for herpes simplex virus
NL300165I1 (nl) Babesiavaccine.
KR970703417A (ko) 유두종 바이러스 백신(Papillomavirus vaccines)